Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EHAB
EHAB logo

EHAB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Enhabit Inc (EHAB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
13.980
1 Day change
-0.07%
52 Week Range
14.220
Analysis Updated At
2026/04/10
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Enhabit Inc (EHAB) is not a compelling buy for a beginner, long-term investor at this time. The stock is trading at $13.99, which is close to the acquisition price of $13.80 per share in an all-cash deal by Kinderhook Industries. This limits the potential for significant upside. Additionally, the company's financial performance shows declining net income and EPS, which are not favorable for long-term growth. The technical indicators are mixed, with no clear bullish signal, and there are no significant positive catalysts or trading signals to suggest immediate action.

Technical Analysis

The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 70.199, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 14.154), suggesting limited upside potential. Overall, the technical indicators do not provide a strong buy signal.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
9

Positive Catalysts

  • The company has been acquired by Kinderhook Industries in an all-cash transaction valued at $13.80 per share. This provides stability and a clear exit price for current shareholders.

Neutral/Negative Catalysts

  • Declining financial performance in 2025/Q4, with net income down 15.87% YoY and EPS down 17.39% YoY. No recent news or significant trading activity from insiders, hedge funds, or Congress. Limited upside due to acquisition price cap.

Financial Performance

In 2025/Q4, revenue increased by 4.73% YoY to $270.4M, but net income dropped by 15.87% YoY to -$38.7M. EPS also declined by 17.39% YoY to -$0.76. Gross margin improved slightly to 46.86%, up 3.24% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Jefferies downgraded the stock to Hold from Buy with a price target of $13.80, citing the acquisition by Kinderhook Industries. Oppenheimer upgraded the stock to Outperform earlier in the year with a $14 price target, citing operational improvements and favorable industry trends. However, the acquisition limits further upside.

Wall Street analysts forecast EHAB stock price to fall
5 Analyst Rating
Wall Street analysts forecast EHAB stock price to fall
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 13.990
sliders
Low
10.5
Averages
12.2
High
14
Current: 13.990
sliders
Low
10.5
Averages
12.2
High
14
Jefferies
Buy
to
Hold
downgrade
AI Analysis
2026-02-23
Reason
Jefferies
Price Target
AI Analysis
2026-02-23
downgrade
Buy
to
Hold
Reason
Jefferies downgraded Enhabit to Hold from Buy with a price target of $13.80, up from $12.50, following the company's agreement to be acquired by Kinderhook Industries in an all-cash transaction valued at $13.80 per share.
Oppenheimer
Perform
to
Outperform
upgrade
$14
2026-01-22
Reason
Oppenheimer
Price Target
$14
2026-01-22
upgrade
Perform
to
Outperform
Reason
Oppenheimer upgraded Enhabit to Outperform from Perform with a $14 price target. The firm believes the post-acute care group is benefiting from "major tailwinds," including strong demand, a more stable regulatory environment, and improving labor trends. Enhabit is positioned to benefit from an improved reimbursement outlook, the analyst tells investors in a research note. In addition, Oppenheimer says the company's operational initiatives should drive the business going forward.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EHAB
Unlock Now

People Also Watch